Trial Profile
The efficacy of AST-120 on chronic kidney disease with stable angina: randomized controlled open-labeled trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2018
Price :
$35
*
At a glance
- Drugs Charcoal (Primary)
- Indications Renal failure
- Focus Pharmacodynamics
- 15 Apr 2018 Status changed from not yet recruiting to completed.
- 24 Dec 2014 New trial record